Overview News About Filings Financials Offerings
SHFH price & chart Provider market data
TradingView · Data may be delayed
About the company Scientist Home Future Health Limited is a Nevada corporation and is not a Chinese operating company. Scientist Home Future Health Limited operates through its wholly owned subsidiary in Hong Kong, Scientist Home HK, which specializing in the retail trading of health supplements and topical creams. Currently, Scientist Home HK sells its products in Hong Kong and plans to expand into neighboring markets across Asia. The Company aims to address current health challenges while supporting long-term wellness for a diverse customer base. (For details, please refer to Future Plan Section).
S-1/A · 2025-04-16 · 0002032609-25-000005
Company description from the cited filing.
In the news No coverage from other publishers is available.
Financials FY 2025 · USD Revenue 197,447 USD · FY 2025 Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Net income -231,725 USD · FY 2025 Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Assets 644,365 USD · FY 2025 Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
Cash — · FY 2025 Operating income -231,725 USD · FY 2025 Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Diluted EPS -0.01 USD per share · FY 2025 Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Some figures are unavailable for this reporting year.
balance sheet · annual statements Line item FY 2025 FY 2024 ASSETS Assets USD 644,365Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
21,248Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Property, Plant and Equipment, Net USD 73,175Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
0Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2024-12-31
Current assets: Inventory, Net USD 34,006Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
2,627Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Assets, Current USD 192,246Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
21,248Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Operating Lease, Right-of-Use AssetUSD 378,944Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
0Source 10-Q · 2025-11-12 · 0001477932-25-008029
As of 2024-12-31
LIABILITIES AND EQUITY Liabilities USD 530,974Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
27,268Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Stockholders’ equity: Common Stock, Value, IssuedUSD 2,372Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
2,348Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Additional Paid in CapitalUSD 360,588Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
6,612Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Retained Earnings (Accumulated Deficit)USD -246,705Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
-14,980Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Accumulated Other Comprehensive Income (Loss), Net of TaxUSD -2,864Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
0Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Stockholders' Equity Attributable to Parent USD 113,391Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
-6,020Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Liabilities and Equity USD 644,365Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
21,248Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Current liabilities: Liabilities, Current USD 214,458Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
27,268Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Operating Lease, Liability, CurrentUSD 74,167Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
0Source 10-Q · 2025-11-12 · 0001477932-25-008029
As of 2024-12-31
Operating Lease, Liability, NoncurrentUSD 316,516Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
0Source 10-Q · 2025-11-12 · 0001477932-25-008029
As of 2024-12-31
Additional Financial Items Accrued Liabilities, CurrentUSD 23,703Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
15,000Source 10-Q · 2025-11-12 · 0001477932-25-008029
As of 2024-12-31
Lines labelled “Derived” are calculated from reported figures.
cash flow · annual statements Line item FY 2025 FY 2024 Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -231,725Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Adjustments to reconcile net income to net cash provided by operating activities: Changes in operating assets and liabilities: Increase (Decrease) in InventoriesUSD 31,324Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Deferred Income Tax Expense (Benefit)USD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Net Cash Provided by (Used in) Operating Activities USD -248,278Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities USD -74,774Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Payments to Acquire Property, Plant, and EquipmentUSD 74,774Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities USD 376,140Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD 68,888Source 10-K · 2026-03-27 · 0001477932-26-001618
As of 2025-12-31
18,621Source 10-Q · 2025-05-15 · 0001477932-25-003833
As of 2024-12-31
Supplemental disclosure of cash flow information: Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Income Taxes Paid, NetUSD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD -2,821Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Additional Financial Items DepreciationUSD 1,714Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Income Tax Expense (Benefit)USD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Net Income (Loss) Attributable to Parent USD -231,725Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Operating ExpensesUSD -313,612Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
— Proceeds from Issuance of Common StockUSD 354,000Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
—
Lines labelled “Derived” are calculated from reported figures.
income statement · annual statements Line item FY 2025 Total Revenue USD 197,447Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Cost of RevenueUSD 1,093Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Selling, General and Administrative ExpenseUSD 313,612Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Operating Income (Loss) USD -231,725Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -231,725Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Income Tax Expense (Benefit) USD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Net Income (Loss) Attributable to Parent USD -231,725Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Earnings Per Share, DilutedUSD per share -0.01Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Weighted Average Number of Shares Outstanding, Diluted shares 23,590,425Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Additional Financial Items Cost of Goods and Services Sold — Current Income Tax Expense (Benefit)USD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Gross Profit USD 81,887Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Operating ExpensesUSD -313,612Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Other Cost of Operating RevenueUSD 121,075Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Other ExpensesUSD 34,212Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Other IncomeUSD 0Source 10-K · 2026-03-27 · 0001477932-26-001618
2025-01-01 to 2025-12-31
Lines labelled “Derived” are calculated from reported figures.
Offerings Registration 333-283430 S-1/A · 2025-04-16 · 0002032609-25-000005
Terms from the governing filing for this registration; not a claim that the offering is open today.